A detailed history of Pathstone Holdings, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Pathstone Holdings, LLC holds 60,660 shares of ZTS stock, worth $10.7 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
60,660
Previous 60,350 0.51%
Holding current value
$10.7 Million
Previous $10.5 Million 13.28%
% of portfolio
0.05%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$172.58 - $196.48 $53,499 - $60,908
310 Added 0.51%
60,660 $11.9 Million
Q2 2024

Aug 14, 2024

BUY
$145.54 - $178.83 $235,338 - $289,168
1,617 Added 2.75%
60,350 $10.5 Million
Q1 2024

May 13, 2024

SELL
$165.67 - $199.94 $20,543 - $24,792
-124 Reduced 0.21%
58,733 $9.94 Million
Q4 2023

Feb 14, 2024

BUY
$151.44 - $200.09 $8.91 Million - $11.8 Million
58,857 New
58,857 $11.6 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.9B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Pathstone Holdings, LLC Portfolio

Follow Pathstone Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Holdings, LLC with notifications on news.